HomeComparePAYOW vs MRK

PAYOW vs MRK: Dividend Comparison 2026

PAYOW yields 273.97% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PAYOW wins by $829.70M in total portfolio value
10 years
PAYOW
PAYOW
● Live price
273.97%
Share price
$0.73
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$829.76M
Annual income
$482,976,705.87
Full PAYOW calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PAYOW vs MRK

📍 PAYOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPAYOWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PAYOW + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PAYOW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAYOW
Annual income on $10K today (after 15% tax)
$23,287.67/yr
After 10yr DRIP, annual income (after tax)
$410,530,199.99/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PAYOW beats the other by $410,521,871.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAYOW + MRK for your $10,000?

PAYOW: 50%MRK: 50%
100% MRK50/50100% PAYOW
Portfolio after 10yr
$414.91M
Annual income
$241,493,252.00/yr
Blended yield
58.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PAYOW
No analyst data
Altman Z
0.2
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAYOW buys
0
MRK buys
0
No recent congressional trades found for PAYOW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPAYOWMRK
Forward yield273.97%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$829.76M$56.8K
Annual income after 10y$482,976,705.87$9,798.13
Total dividends collected$793.91M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PAYOW vs MRK ($10,000, DRIP)

YearPAYOW PortfolioPAYOW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$38,097$27,397.26$11,206$366.19+$26.9KPAYOW
2$138,312$97,547.72$12,650$502.35+$125.7KPAYOW
3$478,971$330,977.72$14,407$694.19+$464.6KPAYOW
4$1,583,686$1,071,187.07$16,585$967.82+$1.57MPAYOW
5$5,004,645$3,310,100.73$19,342$1,363.89+$4.99MPAYOW
6$15,130,978$9,776,007.79$22,913$1,947.19+$15.11MPAYOW
7$43,813,187$27,623,040.05$27,662$2,823.89+$43.79MPAYOW
8$121,632,577$74,752,467.62$34,159$4,173.35+$121.60MPAYOW
9$324,095,536$193,948,677.87$43,337$6,308.80+$324.05MPAYOW
10$829,758,929$482,976,705.87$56,776$9,798.13+$829.70MPAYOW

PAYOW vs MRK: Complete Analysis 2026

PAYOWStock

Payoneer Global Inc. operates as a financial technology company. It operates a payment infrastructure platform that provides customers with a one-stop, global, multi-currency account to serve their accounts receivable and accounts payable needs. The company delivers a suite of services that includes cross-border payments, physical and virtual MasterCard cards, working capital, risk management, and other services. It also offers various payment options with minimal integration required, full back-office functions, and customer support offered. The company's platform delivers bank-grade security, stability, and redundancy. It serves customers, such as small and medium-sized businesses in approximately 190 countries and territories worldwide. Payoneer Global Inc. was founded in 2005 and is headquartered in New York, New York.

Full PAYOW Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PAYOW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAYOW vs SCHDPAYOW vs JEPIPAYOW vs OPAYOW vs KOPAYOW vs MAINPAYOW vs JNJPAYOW vs ABBVPAYOW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.